What are the best peptides for immune support?
The peptide with the most real human research behind it is thymosin alpha-1 (also called thymalfasin, brand name Zadaxin). After that, the evidence drops off quickly. LL-37, KPV, thymulin, tuftsin, splenopentin, and DSIP all have interesting laboratory and early research, but none has the large, repeated human trials that would make it a proven immune therapy in the US. Importantly, none of these is FDA-approved in the United States for immune support.
Here is the honest hierarchy.
| Peptide | What it is studied for | Evidence base | US FDA status |
|---|---|---|---|
| Thymosin alpha-1 | Immune modulation, hepatitis B, chemo adjunct | Strongest, many human trials abroad | Not US-approved; approved in 30+ countries |
| LL-37 | Antimicrobial, innate immunity | Mostly lab and early studies | Not approved |
| KPV | Anti-inflammatory | Early/preclinical | Not approved |
| Thymulin | T-cell support | Older, limited | Not approved |
| Tuftsin | Macrophage activation | Older, limited | Not approved |
| Splenopentin | Cellular immunity | Very limited | Not approved |
| DSIP | Sleep, indirect immune | Limited, indirect | Not approved |
Is thymosin alpha-1 the best immune peptide?
It is the best-studied. Thymosin alpha-1 is a 28-amino acid peptide derived from the thymus, and it acts as an immunomodulator that influences T-cell function. It is approved in roughly 30 or more countries (including Italy and China) for chronic hepatitis B and as an adjunct in some cancer settings, and it has been studied in many human trials over several decades. A large body of research and reviews supports its use abroad in those specific contexts.
The catch for US readers: thymosin alpha-1 is not FDA-approved in the United States, and in 2023 the FDA added restrictions affecting its compounding here. So while the science is real, US access is limited and legally constrained.
What is LL-37 and does it boost immunity?
LL-37 is the only human cathelicidin antimicrobial peptide. The body makes it naturally as part of innate immune defense, and it can disrupt bacteria, viruses, and fungi in laboratory settings while also influencing immune signaling. That makes it genuinely interesting to researchers.
From the FormBlends catalog
LL-37
The body's natural antimicrobial defense peptide · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View LL-37 →The gap is human evidence. Most LL-37 data comes from lab and animal studies. There are no large controlled human trials establishing LL-37 supplementation as a safe, effective immune therapy, and it is not FDA-approved. Claims of specific "percent fewer infections" from supplementation are not supported by solid human trials. There is also a more subtle concern: LL-37 has been studied as a potential driver of inflammation in some autoimmune conditions, so the idea that more of it is automatically good for everyone is not well founded.
What is KPV used for?
KPV is a tripeptide fragment of alpha-melanocyte stimulating hormone studied for anti-inflammatory effects, particularly in gut and skin inflammation models. The early research is promising at the laboratory level, but human clinical trial data is limited, and KPV is not FDA-approved. It should be viewed as investigational, not proven. The same caution applies to the remaining peptides on the old list. Thymulin, tuftsin, splenopentin, and DSIP all have older or small research footprints, none has large modern human trials, and none is FDA-approved for immune support. Marketing that ranks them with precise "evidence scores" is presenting confidence the underlying data does not support.
LL-37 vs thymosin alpha-1: which is better for immunity?
They do different things. Thymosin alpha-1 is an immune modulator with a large human evidence base abroad, used mainly for chronic viral infection and as a chemo adjunct. LL-37 is a direct antimicrobial peptide that is still mostly at the laboratory and early-research stage in people. If you are weighing evidence quality, thymosin alpha-1 is far ahead. Neither is FDA-approved in the US.
Are immune peptides safe and legal?
Most of these peptides are sold as research chemicals labeled not for human consumption, with unregulated purity. Thymosin alpha-1 has a reasonable safety record in the countries where it is approved, but it is not US-approved and its US compounding is restricted. The others lack long-term human safety data. Injecting unregulated peptides also carries contamination and dosing risks. None of these should replace vaccines, hygiene, or standard medical care.
It is also worth being clear about what "immune support" should mean. A healthy immune system is balanced, not maximally stimulated. The basics with the most evidence behind them are unglamorous: adequate sleep, regular physical activity, a diet with enough protein and micronutrients, not smoking, managing chronic conditions, and keeping vaccinations current. Those do more for real-world immune resilience than any unapproved peptide, and they carry none of the regulatory or contamination risk.
How FormBlends fits in
FormBlends works in the compounded medication space and follows the research on these compounds closely.
FormBlends offers physician-supervised, compounded GLP-1 weight management with semaglutide and tirzepatide. Obesity itself is linked to worse immune and inflammatory profiles, so for some people, improving metabolic health through supervised weight management is a more evidence-based investment than an unapproved immune peptide.
Frequently asked questions
What is the single best-researched immune peptide? Thymosin alpha-1. It has the largest human evidence base, though it is not FDA-approved in the US.
Is thymosin alpha-1 FDA-approved? Not in the United States. It is approved in roughly 30 or more other countries for hepatitis B and as a chemo adjunct, and US compounding was restricted in 2023.
Does LL-37 prevent infections in people? There is no large human trial proving that. LL-37 evidence is mostly laboratory and early-stage, and it is not FDA-approved.
Can immune peptides replace vaccines? No. None of these is a substitute for vaccines or standard preventive care.
Are these peptides legal to buy? Most are sold as research chemicals not for human consumption, with unregulated purity. They are not FDA-approved.
Is KPV proven for autoimmune conditions? No. KPV is investigational, with limited human data and no FDA approval.
Sources
- King-Smith / overview of thymosin alpha-1 (thymalfasin) global approvals and hepatitis B use, PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=thymalfasin+hepatitis+B
- Garaci E. et al., Thymosin alpha 1 clinical applications review, PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=thymosin+alpha+1+clinical
- Vandamme D. et al., LL-37 cathelicidin biology and antimicrobial activity review, PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=LL-37+cathelicidin
- FDA, Compounding and the FDA, questions and answers (peptide compounding restrictions): https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- Dalmau-Mena / KPV anti-inflammatory peptide research, PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=KPV+peptide+anti-inflammatory
Ready when you are
LL-37
The body's natural antimicrobial defense peptide · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View LL-37 →